scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1036742137 |
P356 | DOI | 10.1186/1471-2407-13-123 |
P932 | PMC publication ID | 3651725 |
P698 | PubMed publication ID | 23496812 |
P5875 | ResearchGate publication ID | 236051235 |
P2093 | author name string | Peng Gao | |
Miao Yu | |||
Hui-mian Xu | |||
Jing-xu Sun | |||
Lin-lin Tong | |||
Ying-ying Xu | |||
Yong-xi Song | |||
Zhen-ning Wang | |||
P2860 | cites work | Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 |
Revised TN categorization for colon cancer based on national survival outcomes data | Q33516922 | ||
Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes | Q33627785 | ||
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging | Q33982101 | ||
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? | Q43742675 | ||
Lymph nodes, tumor deposits, and TNM: are we getting better? | Q43868593 | ||
Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective | Q44296108 | ||
Analysis of the seventh edition of American Joint Committee on colon cancer staging | Q48791433 | ||
Bayesian information criterion for censored survival models. | Q52118297 | ||
Revised staging: is it really better, or do we not know? | Q53755343 | ||
Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea | Q57226367 | ||
Current TNM staging of colorectal cancer | Q80572839 | ||
A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer | Q84885032 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 123 | |
P577 | publication date | 2013-03-17 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database | |
P478 | volume | 13 |
Q36696374 | A report of the frequency of colorectal carcinoma and involved lymph nodes in South-West Iran |
Q42398672 | Case Report: Collision Tumour of Colon Leiomyosarcoma and Adenocarcinoma |
Q37593956 | Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer |
Q55071626 | Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer. |
Q99608966 | ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation |
Q36297989 | Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy |
Q35068085 | Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy |
Q51307767 | Koelreuteria Formosana Extract Induces Growth Inhibition and Cell Death in Human Colon Carcinoma Cells via G2/M Arrest and LC3-II Activation-Dependent Autophagy. |
Q40312006 | Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer. |
Q36151978 | Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer |
Q64981746 | Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection. |
Q37564560 | Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression |
Q36571451 | Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer. |
Q64063399 | Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles |
Q47428842 | Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. |
Q57485485 | Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis |
Q97525347 | Surgical management and hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer |
Q37683046 | TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability |
Q35024261 | Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases |
Q55408333 | Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma. |
Search more.